Locations
Rehovot, Israel · Center District, Israel
industry
Biotechnology · DeepTech
Size
1 - 10 employees
Stage
Seed
founded in
2020
Gilboa Therapeutics is a preclinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies that utilize the patient's immune system to treat various cancers. Their proprietary Solid T technology, developed in Dr. Yaron Carmi's lab, enables engineered T cell therapies to target solid tumors effectively, improving response rates and patient outcomes. The company aims to address the limitations of current immunotherapies, particularly in solid tumors, by providing a safer and more efficient treatment option. With a strong team of industry experts and a commitment to innovation, Gilboa is positioned to make significant advancements in cancer treatment.
Is this your company?
Something looks off?